insights_auto
Why is MBIO down 3.46%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.46
arrow_downward
-3.46%(-0.017) 1D
$0.47
arrow_upward
+1.23% (+0.0057)bedtimeAfter hours
Closed: Sep 30, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.47
High
$0.47
Low
$0.46
Mkt. cap
3.51M
Avg. vol.
23.83K
Volume
30.47K
52-wk high
$1.84
52-wk low
$0.46
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
Open
$0.47
High
$0.47
Low
$0.46
Mkt. cap
3.51M
Avg. vol.
23.83K
Volume
30.47K
52-wk high
$1.84
52-wk low
$0.46
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
TradingView
·
5 hours ago
Q3 Earnings on Track for 8th Consecutive Quarter of Double-Digit Growth
FXStreet
·
2 hours ago
Dow Jones Industrial Average fades a soft-inflation bounce as yields climb
marketscreener.com
·
3 hours ago
Bonds post worst month in years; stocks decline for September and oil gains
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com